Ciencias Químicas
Facultad
Instituto Cajal
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto Cajal (23)
2024
-
The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls
EMBO Molecular Medicine, Vol. 16, Núm. 4, pp. 755-783
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process
Gut Microbes, Vol. 12, Núm. 1
-
Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure
Neuropsychopharmacology, Vol. 45, Núm. 5, pp. 877-886
-
Synthesis, antioxidant properties and neuroprotection of α-phenyl-tert-butylnitrone derived HomoBisNitrones in in vitro and in vivo ischemia models
Scientific Reports, Vol. 10, Núm. 1
2019
-
E3 ubiquitin ligases LNX1 and LNX2 are major regulators of the presynaptic glycine transporter GlyT2
Scientific Reports, Vol. 9, Núm. 1
2018
-
Development of a Fluorescent Bodipy Probe for Visualization of the Serotonin 5-HT
1A
Receptor in Native Cells of the Immune System
Bioconjugate Chemistry, Vol. 29, Núm. 6, pp. 2021-2027
-
2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs
GLIA, Vol. 66, Núm. 7, pp. 1447-1463
2017
-
2-arachidonoylglycerol reduces proteoglycans and enhances remyelination in a progressive model of demyelination
Journal of Neuroscience, Vol. 37, Núm. 35, pp. 8385-8398
2015
-
A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways
Journal of Neuroimmune Pharmacology, Vol. 10, Núm. 2, pp. 309-317
-
Endocannabinoids drive the acquisition of an alternative phenotype in microglia
Brain, Behavior, and Immunity, Vol. 49, pp. 233-245
2014
-
A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis
Angewandte Chemie - International Edition, Vol. 53, Núm. 50, pp. 13765-13770
2012
-
Chemical probes for the recognition of cannabinoid receptors in native systems
Angewandte Chemie - International Edition, Vol. 51, Núm. 28, pp. 6896-6899
2011
-
Prospects for cannabinoid therapies in basal ganglia disorders
British Journal of Pharmacology, Vol. 163, Núm. 7, pp. 1365-1378
2006
-
El sistema cannabinoide en situaciones de neuroinflamación: Perspectivas terapéuticas en la esclerosis múltiple
Revista de Neurologia, Vol. 43, Núm. 9, pp. 541-548
2005
-
Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis
FASEB Journal, Vol. 19, Núm. 10, pp. 1338-1340
-
Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures
GLIA, Vol. 52, Núm. 2, pp. 163-168
-
Prevention of Alzheimer's disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation
Journal of Neuroscience, Vol. 25, Núm. 8, pp. 1904-1913
-
The role of cannabinoids in preventing the neurodegenerative process occurring in Alzheimer's disease
Drugs of the Future, Vol. 30, Núm. 8, pp. 807-814
2002
-
Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway
Journal of Biological Chemistry, Vol. 277, Núm. 39, pp. 36527-36533